Dark

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ

At Close

Jul 10, 2026

0.7285USD+1.195%(+0.0086)56,151

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jul 9, 2026 9:13:30 AM EDT

0.7038USD-2.236%(-0.0161)9,039

After-hours

Jul 9, 2026 4:00:30 PM EDT

0.7199USD+2.564%(+0.0180)2,410

Overview HistoricalExchangesShortsMore

open chart

Market Cap

26.31M

Industry

Biotechnology

NRSN Stats

Avg. Vol. 10 Day

227,783

Avg. Vol. 30 Day

186,569

Employees

Market Cap

26,313,154

Shares Out.

36,099,813

On/Off Exchange

49%/51%

6 Month Beta

0.52

1 Year Beta

1.22

2 Year Beta

0.59

3 Year Beta

0.62

52 Week Low

0.63

52 Week High

2.14

SMA50

0.79

SMA200

0.91

1 Week

+4.73%

1 Month

-1.37%

3 Month

+4.13%

6 Month

-29.23%

1 Year

-64.79%

2 Year

-29.23%

5 Year

-81.96%

Profile

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa

NRSN Stock Summary

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $0.7285, and today's volume is 56,151. NRSN is up 1.195% today. The 30 day average volume is 186,569. NRSN market cap is 26.31M with 36,099,813 shares outstanding.

.dark-mode .ZNsdcB{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .ZNsdcB{ color: #333333; background-color: white; border: 2px solid #333333; }NRSNNeuroSense Therapeutics Ltd.stock NASDAQ

NRSN Stock Summary

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ